Congratulations to Rare Disease and Orphan Drugs Journal for Achieving Its First CiteScore: 2.1

We are thrilled to announce that the 2025 CiteScore for Rare Disease and Orphan Drugs Journal (RDODJ) has been released by Scopus on June 3, 2026, showing an impressive first CiteScore to 2.1, placing the journal in Q3 in the Medicine [Internal Medicine, #104/179; Genetics (clinical), #77/100]. This underscores the growing impact and recognition of our journal within the academic community.

This achievement reflects the collective efforts of our Editorial Board, whose expertise and dedication uphold the highest standards of excellence; our authors, who consistently contribute cutting-edge research; and our readers, whose ongoing engagement enriches the journal's impact.

Looking ahead, we remain committed to enhancing RDODJ by continuously optimizing our platform, refining our processes, and offering an ever-improving journal experience. Together, we will continue to build a leading publication that fosters impactful research and meaningful scientific exchange.

Thank you for being part of our journey. We look forward to reaching even greater milestones with you.

Editor: Haidi Ding
Language Editor: Amir Khan
Production Editor: Ting Xu
Respectfully Submitted by the Editorial Office of Rare Disease and Orphan Drugs Journal